SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-15
👔
Inhibrx Biosciences, Inc.
@INBX_InsiderForm 4 Filing: MANHARD KIMBERLY Sells $164K of $INBX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Inhibrx Biosciences, Inc.
Ticker: $INBX
Transaction Value
$164K
Price/Share: $109.03
transaction date
2026-09-11
Shares: 1,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MANHARD KIMBERLY, holds the title of Director at Inhibrx Biosciences, Inc..
On 2026-09-11, the insider transacted 1,500 shares.The shares were transacted at a weighted average price of $109.03 per share, resulting in a total market-relevant value of $164K.
Executive Summary Summary
MANHARD KIMBERLY (Director) sold $164K of $INBX
Post-Transaction Position: 8,500 shares
SEC Accession No: 0001202094-26-000006 (CIK: 1202094)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.